Cyclodextrins in Pharmaceutical - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Cyclodextrins in Pharmaceutical should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Cyclodextrins in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Cyclodextrins in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Drug Safety grew percent to account for percent of the total market sales, and Medical Laboratory grew percent.
Cyclodextrins are cyclic oligomers of glucose that have a significant number of applications in the pharmaceutical industries. Water-soluble cyclodextrins can form inclusion complexes with small molecules and portions of large compounds that have limited aqueous solubility to provide improved bioavailability of drugs.
This report studies and analyses global Cyclodextrins in Pharmaceutical status and future trends, helps the client to determine the Cyclodextrins in Pharmaceutical market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Cyclodextrins in Pharmaceutical, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Cyclodextrins in Pharmaceutical market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Cyclodextrins in Pharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Cyclodextrins in Pharmaceutical sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Cyclodextrins in Pharmaceutical key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Cyclodextrins in Pharmaceutical key producing regions, capacity, production, and year over year growth
(6) Cyclodextrins in Pharmaceutical industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Ashland
Cambrex Corporation
Cayman Chemical
Cyclo Therapeutics
Ligand Pharmaceuticals Incorporated
Merck KGaA
Midas Pharma GmbH
Otto Chemie
TCI Chemicals
VIO CHEMICALS
Wacker Chemie AG
Wellona Pharma
Market segment by Type, covers
Solid
Liquid
Market segment by Application, can be divided into
Drug Safety
Medical Laboratory
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Cyclodextrins in Pharmaceutical product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Cyclodextrins in Pharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Cyclodextrins in Pharmaceutical market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Cyclodextrins in Pharmaceutical, percent & CAGR, 2018-2029
Chapter 5: Cyclodextrins in Pharmaceutical industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Cyclodextrins in Pharmaceutical Definition
1.2 Global Cyclodextrins in Pharmaceutical Market Size and Forecast
1.2.1 By Consumption Value, Global Cyclodextrins in Pharmaceutical Market Size，2018-2029
1.2.2 By Sales Quantity, Global Cyclodextrins in Pharmaceutical Market Size，2018-2029
1.2.3 Global Cyclodextrins in Pharmaceutical Average Selling Price (ASP)，2018-2029
1.3 China Cyclodextrins in Pharmaceutical Market Size and Forecast
1.3.1 By Consumption Value, China Cyclodextrins in Pharmaceutical Market Size，2018-2029
1.3.2 By Sales Quantity, China Cyclodextrins in Pharmaceutical Market Size，2018-2029
1.3.3 China Cyclodextrins in Pharmaceutical Average Selling Price (ASP)， 2018-2029
1.4 Share of China Cyclodextrins in Pharmaceutical Market with Respect to the Global Market
1.4.1 By Consumption Value, China Cyclodextrins in Pharmaceutical Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Cyclodextrins in Pharmaceutical Market Share in Global, 2018-2029
1.4.3 Cyclodextrins in Pharmaceutical Market Size: China VS Global, 2018-2029
1.5 Cyclodextrins in Pharmaceutical Market Dynamics
1.5.1 Cyclodextrins in Pharmaceutical Market Drivers
1.5.2 Cyclodextrins in Pharmaceutical Market Restraints
1.5.3 Cyclodextrins in Pharmaceutical Industry Trends
1.5.4 Cyclodextrins in Pharmaceutical Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Cyclodextrins in Pharmaceutical, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Cyclodextrins in Pharmaceutical, Global Market Share by Company, 2018-2023
2.3 Cyclodextrins in Pharmaceutical Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Cyclodextrins in Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Cyclodextrins in Pharmaceutical Concentration Ratio
2.6 Global Cyclodextrins in Pharmaceutical Mergers & Acquisitions, Expansion Plans
2.7 Global Cyclodextrins in Pharmaceutical Manufacturers Product Type
2.8 Head Office and Cyclodextrins in Pharmaceutical Production Site of Key Manufacturer
2.9 Cyclodextrins in Pharmaceutical Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Cyclodextrins in Pharmaceutical, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Cyclodextrins in Pharmaceutical, China Market Share by Company, 2018-2023
3.3 China Cyclodextrins in Pharmaceutical Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Cyclodextrins in Pharmaceutical Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Cyclodextrins in Pharmaceutical Capacity by Region
4.3 Global Cyclodextrins in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Cyclodextrins in Pharmaceutical Production by Region, 2018-2029
4.5 Global Cyclodextrins in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Cyclodextrins in Pharmaceutical Industry Chain
5.2 Cyclodextrins in Pharmaceutical Upstream Analysis
5.2.1 Cyclodextrins in Pharmaceutical Core Raw Materials
5.2.2 Main Manufacturers of Cyclodextrins in Pharmaceutical Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Cyclodextrins in Pharmaceutical Production Mode
5.6 Cyclodextrins in Pharmaceutical Procurement Model
5.7 Cyclodextrins in Pharmaceutical Industry Sales Model and Sales Channels
5.7.1 Cyclodextrins in Pharmaceutical Sales Model
5.7.2 Cyclodextrins in Pharmaceutical Typical Distributors
6 Sights by Type
6.1 Cyclodextrins in Pharmaceutical Classification
6.1.1 Solid
6.1.2 Liquid
6.2 By Type, Global Cyclodextrins in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029
6.4 By Type, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029
6.5 By Type, Global Cyclodextrins in Pharmaceutical Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Cyclodextrins in Pharmaceutical Segment by Application
7.1.1 Drug Safety
7.1.2 Medical Laboratory
7.1.3 Others
7.2 By Application, Global Cyclodextrins in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029
7.4 By Application, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029
7.5 By Application, Global Cyclodextrins in Pharmaceutical Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029
8.3 By Region, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Cyclodextrins in Pharmaceutical & Forecasts, 2018-2029
8.4.2 By Country, North America Cyclodextrins in Pharmaceutical Market Size Market Share
8.5 Europe
8.5.1 Europe Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Cyclodextrins in Pharmaceutical Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Cyclodextrins in Pharmaceutical Market Size Market Share
8.7 South America
8.7.1 South America Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Cyclodextrins in Pharmaceutical Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Cyclodextrins in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029
9.3 By Country, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.4.2 By Type, U.S. Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.5.2 By Type, Europe Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.6.2 By Type, China Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.7.2 By Type, Japan Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.8.2 By Type, South Korea Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.10.2 By Type, India Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Ashland
10.1.1 Ashland Company Information, Head Office, Market Area, and Industry Position
10.1.2 Ashland Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.1.3 Ashland Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Ashland Company Profile and Main Business
10.1.5 Ashland Recent Developments
10.2 Cambrex Corporation
10.2.1 Cambrex Corporation Company Information, Head Office, Market Area, and Industry Position
10.2.2 Cambrex Corporation Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.2.3 Cambrex Corporation Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Cambrex Corporation Company Profile and Main Business
10.2.5 Cambrex Corporation Recent Developments
10.3 Cayman Chemical
10.3.1 Cayman Chemical Company Information, Head Office, Market Area, and Industry Position
10.3.2 Cayman Chemical Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.3.3 Cayman Chemical Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Cayman Chemical Company Profile and Main Business
10.3.5 Cayman Chemical Recent Developments
10.4 Cyclo Therapeutics
10.4.1 Cyclo Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.4.2 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.4.3 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Cyclo Therapeutics Company Profile and Main Business
10.4.5 Cyclo Therapeutics Recent Developments
10.5 Ligand Pharmaceuticals Incorporated
10.5.1 Ligand Pharmaceuticals Incorporated Company Information, Head Office, Market Area, and Industry Position
10.5.2 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.5.3 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Ligand Pharmaceuticals Incorporated Company Profile and Main Business
10.5.5 Ligand Pharmaceuticals Incorporated Recent Developments
10.6 Merck KGaA
10.6.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
10.6.2 Merck KGaA Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.6.3 Merck KGaA Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Merck KGaA Company Profile and Main Business
10.6.5 Merck KGaA Recent Developments
10.7 Midas Pharma GmbH
10.7.1 Midas Pharma GmbH Company Information, Head Office, Market Area, and Industry Position
10.7.2 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.7.3 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Midas Pharma GmbH Company Profile and Main Business
10.7.5 Midas Pharma GmbH Recent Developments
10.8 Otto Chemie
10.8.1 Otto Chemie Company Information, Head Office, Market Area, and Industry Position
10.8.2 Otto Chemie Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.8.3 Otto Chemie Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Otto Chemie Company Profile and Main Business
10.8.5 Otto Chemie Recent Developments
10.9 TCI Chemicals
10.9.1 TCI Chemicals Company Information, Head Office, Market Area, and Industry Position
10.9.2 TCI Chemicals Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.9.3 TCI Chemicals Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 TCI Chemicals Company Profile and Main Business
10.9.5 TCI Chemicals Recent Developments
10.10 VIO CHEMICALS
10.10.1 VIO CHEMICALS Company Information, Head Office, Market Area, and Industry Position
10.10.2 VIO CHEMICALS Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.10.3 VIO CHEMICALS Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 VIO CHEMICALS Company Profile and Main Business
10.10.5 VIO CHEMICALS Recent Developments
10.11 Wacker Chemie AG
10.11.1 Wacker Chemie AG Company Information, Head Office, Market Area, and Industry Position
10.11.2 Wacker Chemie AG Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.11.3 Wacker Chemie AG Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Wacker Chemie AG Company Profile and Main Business
10.11.5 Wacker Chemie AG Recent Developments
10.12 Wellona Pharma
10.12.1 Wellona Pharma Company Information, Head Office, Market Area, and Industry Position
10.12.2 Wellona Pharma Cyclodextrins in Pharmaceutical Models, Specifications, and Application
10.12.3 Wellona Pharma Cyclodextrins in Pharmaceutical Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Wellona Pharma Company Profile and Main Business
10.12.5 Wellona Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Cyclodextrins in Pharmaceutical Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Cyclodextrins in Pharmaceutical Market Restraints
Table 3. Cyclodextrins in Pharmaceutical Market Trends
Table 4. Cyclodextrins in Pharmaceutical Industry Policy
Table 5. Global Cyclodextrins in Pharmaceutical Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Cyclodextrins in Pharmaceutical Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Cyclodextrins in Pharmaceutical Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Cyclodextrins in Pharmaceutical Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Cyclodextrins in Pharmaceutical Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Cyclodextrins in Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Cyclodextrins in Pharmaceutical Mergers & Acquisitions, Expansion Plans
Table 12. Global Cyclodextrins in Pharmaceutical Manufacturers Product Type
Table 13. Head Office and Cyclodextrins in Pharmaceutical Production Site of Key Manufacturer
Table 14. Cyclodextrins in Pharmaceutical Capacity of Major Manufacturers and Future Plan
Table 15. China Cyclodextrins in Pharmaceutical Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Cyclodextrins in Pharmaceutical Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Cyclodextrins in Pharmaceutical Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Cyclodextrins in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Cyclodextrins in Pharmaceutical Production by Region, 2018-2023, (K Units)
Table 20. Global Cyclodextrins in Pharmaceutical Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Cyclodextrins in Pharmaceutical Upstream (Raw Materials)
Table 22. Global Cyclodextrins in Pharmaceutical Typical Customers
Table 23. Cyclodextrins in Pharmaceutical Typical Distributors
Table 24. By Type, Global Cyclodextrins in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Cyclodextrins in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Cyclodextrins in Pharmaceutical Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2018-2029
Table 34. Ashland Company Information, Head Office, Market Area, and Industry Position
Table 35. Ashland Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 36. Ashland Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Ashland Company Profile and Main Business
Table 38. Ashland Recent Developments
Table 39. Cambrex Corporation Company Information, Head Office, Market Area, and Industry Position
Table 40. Cambrex Corporation Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 41. Cambrex Corporation Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Cambrex Corporation Company Profile and Main Business
Table 43. Cambrex Corporation Recent Developments
Table 44. Cayman Chemical Company Information, Head Office, Market Area, and Industry Position
Table 45. Cayman Chemical Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 46. Cayman Chemical Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Cayman Chemical Company Profile and Main Business
Table 48. Cayman Chemical Recent Developments
Table 49. Cyclo Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 50. Cyclo Therapeutics Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 51. Cyclo Therapeutics Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Cyclo Therapeutics Company Profile and Main Business
Table 53. Cyclo Therapeutics Recent Developments
Table 54. Ligand Pharmaceuticals Incorporated Company Information, Head Office, Market Area, and Industry Position
Table 55. Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 56. Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Ligand Pharmaceuticals Incorporated Company Profile and Main Business
Table 58. Ligand Pharmaceuticals Incorporated Recent Developments
Table 59. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
Table 60. Merck KGaA Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 61. Merck KGaA Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Merck KGaA Company Profile and Main Business
Table 63. Merck KGaA Recent Developments
Table 64. Midas Pharma GmbH Company Information, Head Office, Market Area, and Industry Position
Table 65. Midas Pharma GmbH Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 66. Midas Pharma GmbH Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Midas Pharma GmbH Company Profile and Main Business
Table 68. Midas Pharma GmbH Recent Developments
Table 69. Otto Chemie Company Information, Head Office, Market Area, and Industry Position
Table 70. Otto Chemie Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 71. Otto Chemie Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Otto Chemie Company Profile and Main Business
Table 73. Otto Chemie Recent Developments
Table 74. TCI Chemicals Company Information, Head Office, Market Area, and Industry Position
Table 75. TCI Chemicals Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 76. TCI Chemicals Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. TCI Chemicals Company Profile and Main Business
Table 78. TCI Chemicals Recent Developments
Table 79. VIO CHEMICALS Company Information, Head Office, Market Area, and Industry Position
Table 80. VIO CHEMICALS Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 81. VIO CHEMICALS Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. VIO CHEMICALS Company Profile and Main Business
Table 83. VIO CHEMICALS Recent Developments
Table 84. Wacker Chemie AG Company Information, Head Office, Market Area, and Industry Position
Table 85. Wacker Chemie AG Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 86. Wacker Chemie AG Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Wacker Chemie AG Company Profile and Main Business
Table 88. Wacker Chemie AG Recent Developments
Table 89. Wellona Pharma Company Information, Head Office, Market Area, and Industry Position
Table 90. Wellona Pharma Cyclodextrins in Pharmaceutical Models, Specifications, and Application
Table 91. Wellona Pharma Cyclodextrins in Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Wellona Pharma Company Profile and Main Business
Table 93. Wellona Pharma Recent Developments
List of Figures
Figure 1. Cyclodextrins in Pharmaceutical Picture
Figure 2. Global Cyclodextrins in Pharmaceutical Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Cyclodextrins in Pharmaceutical Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Cyclodextrins in Pharmaceutical Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Cyclodextrins in Pharmaceutical Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Cyclodextrins in Pharmaceutical Sales Quantity (K Units) & (2018-2029)
Figure 7. China Cyclodextrins in Pharmaceutical Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Cyclodextrins in Pharmaceutical Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Cyclodextrins in Pharmaceutical Market Share of Global, 2018-2029
Figure 10. Global Cyclodextrins in Pharmaceutical Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Cyclodextrins in Pharmaceutical Key Participants, Market Share, 2022
Figure 12. Global Cyclodextrins in Pharmaceutical Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Cyclodextrins in Pharmaceutical Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Cyclodextrins in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
Figure 15. Cyclodextrins in Pharmaceutical Industry Chain
Figure 16. Cyclodextrins in Pharmaceutical Procurement Model
Figure 17. Cyclodextrins in Pharmaceutical Sales Model
Figure 18. Cyclodextrins in Pharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 19. Solid
Figure 20. Liquid
Figure 21. By Type, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Cyclodextrins in Pharmaceutical Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Drug Safety
Figure 27. Medical Laboratory
Figure 28. Others
Figure 29. By Application, Global Cyclodextrins in Pharmaceutical Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Cyclodextrins in Pharmaceutical Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2018-2029
Figure 36. North America Cyclodextrins in Pharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2022
Figure 38. Europe Cyclodextrins in Pharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2022
Figure 40. Asia Pacific Cyclodextrins in Pharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2022
Figure 42. South America Cyclodextrins in Pharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Cyclodextrins in Pharmaceutical Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Cyclodextrins in Pharmaceutical Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Research Methodology:
Cyclodextrins in Pharmaceutical Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|